Abnormal GPHN clustering during neurodevelopment is associated with the pathogenesis of neurological, neurodevelopmental, and psychiatric disorders (39), with exonic deletions implicated in the risk for schizophrenia, autism, and epilepsy development (40, 41). This evidence concerns the gene GPHN and epilepsy.